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As high-throughput biochemical screens are both expensive and labor intensive, researchers in academia
and industry are turning increasingly to virtual-screening methodologies. Virtual screening relies on scoring
functions to quickly assess ligand potency. Although useful for in silico ligand identiﬁcation, these scoring
functions generally give many false positives and negatives; indeed, a properly trained human being can
often assess ligand potency by visual inspection with greater accuracy. Given the success of the human
mind at protein-ligand complex characterization, we present here a scoring function based on a neural
network, a computational model that attempts to simulate, albeit inadequately, the microscopic organization
of the brain. Computer-aided drug design depends on fast and accurate scoring functions to aid in the
identiﬁcation of small-molecule ligands. The scoring function presented here, used either on its own or in
conjunction with other more traditional functions, could prove useful in future drug-discovery efforts.
INTRODUCTION
High-throughput biochemical screens, used to identify
pharmacologically active small-molecule compounds, are a
staple of modern drug discovery. In these screens, hundreds
of thousands to even millions of compounds are tested in
highly automated assays. Although robotics and miniaturiza-
tion have led to increased efﬁciency, traditional high-
throughput screens are nevertheless expensive and labor
intensive. With a few notable exceptions, the ﬁnancial and
labor requirements of such screens place them beyond the
reach of most academic institutions.
Consequently, academic researchers, as well as some in
industry, are increasingly turning to virtual screens. Virtual
screens rely on computer docking programs to position
models of potential ligands within target active sites and
predict the binding afﬁnity. Precise physics-based compu-





4 are too time- and calculation-
intensive for use in virtual screens. Instead, researchers have
developed simpler scoring functions that sacriﬁce some
accuracy in favor of greater speed.
5-7 Because of these
accepted inaccuracies, scoring functions are unable to
explicitly identify ligands in silico; rather, they serve only
to enrich the pool of candidate ligands with potential hits.
The compounds with the best predicted binding energies are
subsequently tested in experimental assays to verify activity.
Current scoring functions fall into three general classes.
8
The ﬁrst class, based on molecular force ﬁelds, predicts
binding energy by estimating electrostatic and van der Waals
forces explicitly. Docking programs using force-ﬁeld-based





12 and Gold (GoldScore).
13 A second class of “empiri-
cal” scoring functions include those used by Glide
10,11 and
eHits (SFe empirical scoring function),
14,15 as well as the
ChemScore
16 and Piecewise Linear Potential (PLP)
17 func-
tions. These functions estimate binding energy by calculating
the weighted sum of all hydrogen-bond and hydrophobic
contacts. A third class of scoring function, called “knowledge
based,” relies on statistical analyses of crystal-structure
databases. Pairs of atom types that are frequently found in
close proximity are judged to be energetically favorable.
Examples include the Astex Statistical Potential (ASP)
18 and
the SFs statistical scoring function used by eHits.
14,15
These approaches to binding-afﬁnity prediction have
proven very useful; virtual-screening efforts routinely identify
predicted ligands that are subsequently validated experimen-
tally (see, for example, refs 19 and 20). However, modern
scoring functions produce many false-positive and false-
negative results. Surprisingly, a human being with the proper
training can often analyze a docked structure visually and
correctly assess inhibition with greater accuracy.
8 Remark-
ably, the human mind can characterize ligand binding without
employing physical or chemical equations and without
requiring the explicit calculation of afﬁnity constants.
Although any computational model pales in comparison to
the complexity of the brain, the mind’s ability to categorize
protein-ligand complexes nevertheless suggests that a neural
network, a computer model designed to mimic the micro-
scopic organization of the brain, might be at least as suited
to the prediction of protein-ligand binding afﬁnities as
equation- and statistics-based scoring functions.
Herein, we describe a fast and accurate neural-network-
based scoring function that can be used to rescore the docked
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Published on Web 09/16/2010poses of candidate ligands. The function is in some ways
knowledge based, as it draws upon protein-structure data-
bases to “learn” what structural characteristics favorably
affect binding. However, the use of neural networks in this
context is largely unprecedented.
21 Although useful in its
own right, the neural-network approach to afﬁnity prediction
is also orthogonal to existing physics-based and statistics-
based scoring functions and, so, might prove useful in
consensus-scoring projects as well.
RESULTS AND DISCUSSION
Neural networks are computer models designed to mimic,
albeit inadequately, the microscopic architecture and orga-
nization of the brain. In brief, various “neurodes,” analogous
to biological neurons, are joined by “connections,” analogous
to neuronal synapses. The behavior of the network is
determined not only by the organization and number of the
neurodes, but also by the weights (i.e., strengths) of the
connections.
All neural networks have at least two layers. The ﬁrst,
called the input layer, receives information about the system
the network is to analyze. The second, called the output layer,
encodes the results of that analysis. Additionally, optional
hidden layers receive input from the input layer and transmit
it to the output layer, allowing for even more complex
behavior (Figure 1).
In designing a neural network to analyze a complex data
set, the speciﬁc formulas that describe the relationships
between data-set characteristics need not be explicitly
delineated; rather, the designer need only provide the network
with an adequate description of the system so that the
network can infer those relationships on its own. In the
current context, creating neural networks to characterize
the binding afﬁnity of protein-ligand complexes does not
require that we implement or even understand the speciﬁc
formulaic relationships that describe van der Waals, elec-
trostatic, and hydrogen-bond interactions, though the energies
calculated by these formulas can in theory be included in
the network input.
21 Rather, we must determine what
characteristics of a protein-ligand complex the network
needs to “see” in order to correctly analyze and characterize
the complex on its own.
What Properties of a Protein-Ligand Complex De-
termine Binding Afﬁnity? Ligand binding afﬁnity is
determined by both enthalpic and entropic factors. Speciﬁc
atom-atom interactions, including electrostatic, hydrogen-
bond, van der Waals, π-π, and π-cation interactions,
contribute to the enthalpic component of the binding energy.
In contrast, the entropic contribution is determined in part
by the number of ligand rotatable bonds and the challenges
of disordering and rearranging the ordered hydration shells
surrounding the unbound ligand and the apo active site. The
entropic penalty related to hydration is difﬁcult to calculate
explicitly and is likely a function of many factors, including
the hydrophobicity and volume of the ligand, the number of
buried but unsatisﬁed hydrogen-bond donors and acceptors
upon binding, and the protein-ligand contact surface area.
In the current work, we therefore sought to identify the
characteristics of protein-ligand complexes that might affect
these enthalpic and entropic factors.
First, the proximity of ligand and protein atoms likely
contributes to the binding afﬁnity by affecting enthalpic
factors (i.e., electrostatic, van der Waals, hydrogen-bond,
π-π, and π-cation interactions), as well as entropic factors
(i.e., buried but unsatisﬁed hydrogen bonds and the size of
the protein-ligand contact area). In the current context, this
proximity information is stored in a proximity list. The
distances between the atoms of the ligand and the protein
are considered; atoms that are close to each other are
subsequently grouped by their corresponding AutoDock atom
types, and the number of each atom-type pair is tallied.
Second, electrostatic interactions contribute to the enthalpic
component of the binding energy through salt bridges and
hydrogen bonds. The electrostatic energy is certainly de-
pendent on proximity, but it is also dependent on partial
atomic charges. Consequently, for each of the atom-type pairs
in the proximity list described above, a summed electrostatic
energy is also calculated from the assigned Gasteiger charges.
Third, certain ligand characteristics related to the quantity
and identity of ligand atom types, such as ligand hydropho-
bicity and volume, could affect the entropy of binding as
well. Consequently, all of the atoms of the ligand are
categorized by their corresponding atom types. Finally, the
number of rotatable bonds in the ligand is explicitly counted,
as ligand ﬂexibility can also have an important impact on
entropy.
Developing Neural Networks to Analyze These Proper-
ties of Protein-Ligand Complexes. When all of these atom-
type pairs, ligand atom types, and other metrics are consid-
ered separately, a given protein-ligand complex can be
characterized across 194 dimensions; thus, we created neural
networks with input layers containing 194 neurodes. As
output, only two neurodes are needed to distinguish between
good and poor binders: (1, 0) indicates that a given
protein-ligand complex has a dissociation constant Kd < 25
µM, and (0, 1) indicates that a given complex has Kd > 25
µM. Although somewhat arbitrary, our experience with
virtual screening has led us to believe that 25 µMi sa
reasonable cutoff for distinguishing between inhibitors that
warrant further study and optimization and poor inhibitors
that are best not pursued further.
Figure 1. Schematic of a simple neural network. All neural
networks have an input layer, through which information about the
system to be analyzed is passed, and an output layer, which encodes
the results of the analysis. Optional hidden layers receive input from
the input layer and transmit it to the output layer, allowing for even
more complex behavior.
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complexes were downloaded from the Protein Data Bank
22
and characterized across the 194 dimensions described above.
These 4141 complexes included 2695 unique, diverse protein
structures mapping to over 600 UniProt primary accession
numbers. Of these 4141 complexes, 2710 had Kd values that
had been experimentally measured; 2022 of these were good
binders (Kd < 25 µM), and 688 were poor binders (Kd g 25
µM). Recognizing that the poor binders were underrepre-
sented, additional complexes of poorly binding ligands were
obtained by docking compounds of the NCI Diversity Set II
into the same protein receptors as used previously. One
thousand four hundred thirty-one of these dockings into 571
unique PDB structures had highest-ranked ligand poses with
predicted binding energies between 0 and -4 kcal/mol. These
were also included in the database of protein-ligand
complexes as examples of weak binders.
Preliminary Studies to Validate the Model. Multiple
neural networks were trained to study the inﬂuence of
network architecture and training-set size on accuracy and
to judge the robustness of the network output. Ultimately, a
network architecture consisting of a single hidden layer of
ﬁve neurodes was selected. Training sets of 1, 10, 25, 50,
100, 250, 500, 1000, 2000, 3000, and 4000 protein-ligand
complexes were generated by randomly selecting complexes
from among the 4141 complexes previously characterized.
Random training sets were generated for each network to
ensure that network accuracy was independent of the
complexes chosen for inclusion. In all cases, the remaining
complexes were used as a validation set to verify that the
networks had not been overtrained and to judge training
effectiveness.
Each individual network has its own unique strengths and
weaknesses; to obtain consistent results across multiple
protein-ligand complexes, it is better to take the average
prediction of multiple networks rather than to trust the
prediction of any single network. For each training-set size
described above, we therefore trained 10 independent neural
networks and averaged the corresponding outputs (Figure
2).
Figure 2 depicts the accuracy of these neural networks,
that is, the frequency with which they accurately character-
ized the protein-ligand complexes of their respective training
and validation sets as either having high afﬁnity (Kd < 25
µM) or low afﬁnity (Kd > 25 µM). Although trained to give
a binary response [(1, 0) for strong binding, (0, 1) for weak
binding], network output was in fact continuous [(a, b),
where a + b ) 1.0 because network outputs were normal-
ized]. To evaluate each protein-ligand complex, a score (n
) a - b) was calculated. If n > 0, the network output was
interpreted to predict Kd < 25 µM; otherwise, it predicted
Kd > 25 µM.
The accuracy with which the networks were able to
characterize the binding constants of the protein-ligand
complexes in their respective training sets (i.e., those
complexes to which the network had already been “exposed”)
is shown in Figure 2, in blue. Interestingly, training-set
accuracy was good regardless of training-set size.
The networks’ ability to correctly characterize the
protein-ligand complexes of their respective validation sets,
sets comprising complexes that had never been seen before,
was far more indicative of true predictive ability. The
accuracies of these predictions (Figure 2, in green) clearly
demonstrate that overtraining had not occurred, as accuracy
consistently improved with exposure to larger training sets.
After having been exposed to only 1000 examples, the
networks were already quite good at characterizing protein-
ligand complexes; however, additional examples did result
in moderate improvements in accuracy. We note also that,
for training-set sizes greater than 1000, the standard deviation
of the outputs of the 10 networks associated with each
training-set size was relatively small, suggesting that network
output was largely independent of the training set selected.
The single best network of all those tested correctly
characterized the protein-ligand complexes of its training
and validation sets with 94.8% and 87.9% accuracy,
respectively.
Accuracy can be divided into two parts. The true-positive
rate (Figure 2, in purple) indicates the likelihood that a given
protein-ligand complex has a Kd value less than 25 µM
given that the network predicts high-afﬁnity binding. The
true-negative rate (Figure 2, in red) indicates the likelihood
that a given protein-ligand complex has a binding afﬁnity
greater than 25 µM given that the network predicts poor
binding. The true-positive and true-negative rates of these
networks are roughly equal regardless of training-set size;
these networks are just as good at identifying true inhibitors
as they are at identifying poor ones.
Training Additional Networks to Improve Accuracy.
Having conﬁrmed that the networks were not overtrained
and that network output was robust regardless of the
composition of the training sets, we next sought to train
additional networks to determine whether accuracy could be
improved. Ten networks with training sets of 4000 randomly
selected complexes were generated in the preliminary studies
Figure 2. Accuracy of protein-ligand complex characterization.
The x axis shows the size of the training set, and the y axis shows
the percent accuracy. Each data point represents the average
accuracy of 10 independent neural networks with one hidden layer
of ﬁve neurodes. Error bars represent standard deviations. In blue
are shown the accuracies with which the various networks were
able to characterize the binding constants of the protein-ligand
complexes in their respective training sets. In green are shown the
accuracies with which the various networks were able to character-
ize the binding constants of the complexes in their respective
validation sets. In purple is shown the likelihood that a given
protein-ligand complex has a Kd value less than 25 µM given that
the network predicts high-afﬁnity binding (i.e., the true-positive
rate when the respective validation sets were analyzed). In red is
shown the likelihood that a given protein-ligand complex has a
binding afﬁnity greater than 25 µM given that the network predicts
poor binding (i.e., the true-negative rate when the respective
validation sets were analyzed).
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networks could be trained, we generated an additional 1000
independent neural networks with similar training sets of
4000 randomly selected protein-ligand complexes. In each
case, the remaining 141 complexes were again used as a
validation set. Three of these 1000 networks emerged as the
most accurate (89.4% accuracy on the validation set); 24
had validation-set accuracies greater than 87.5%.
Recalling that each network is unique and that consistent
results are best obtained when the average prediction of
multiple networks is considered, we deﬁned a single score,
called an NNScore (N), obtained by averaging the outputs
of these 24 networks.
Can N Be Used as a Scoring Function? To assess how
the NNScore (N) varied according to the experimentally
measured Kd values, we considered the scores of the 2710
characterized protein-ligand complexes with known Kd
values described above. To facilitate visualization, the data
were ordered by the log10(Kd) value. Moving averages of
both the log10(Kd) values and the associated N values were
calculated over 100 points and are plotted in Figure 3.
Unaveraged data points are shown as gray circles. It is
interesting to note that the data-averaged function crosses
the x axis at roughly 25 µM [log10(25 × 10-6) )- 4.60], as
expected. So remarkable is this result that one again wonders
whether the networks were overtrained; however, as Figure
2 demonstrates, these networks were consistently able to
predict the binding of ligands to which they had never been
exposed, suggesting the development of a genuine inductive
bias.
Despite the fact that the networks were trained to answer
what is essentially a yes-or-no question, Figure 3 demon-
strates that they can nevertheless perceive certain “shades
of gray”, that is, they can distinguish not only between good
and poor binders, but, to a certain extent, even between good
and better binders. Given that N decreases somewhat
monotonically as log10(Kd) increases, it might therefore be
possible to use N as a scoring function.
Can N Distinguish between Well- and Poorly Docked
Ligands? A good scoring function should be able to
distinguish between ligands that are well docked and ligands
that are poorly docked. To determine whether or not the
NNScore could make this distinction, we generated a
database of poorly docked ligands separate from the training/
testing database described above. Selected ligands from the
4141 previously characterized protein-ligand complexes
were redocked back into their corresponding receptors using
AutoDock Vina.
23 In 287 cases, the predicted binding energy
of the worst-docked pose was greater than -4 kcal/mol.
These 287 worst-docked poses, together with their associated
protein receptors, were included in the poorly docked
database.
The top three neural networks of the 1000 generated were
each used to characterize these 287 poorly docked binding
poses. These three networks correctly identiﬁed the ligands
as poor binders 94.1%, 88.9%, and 95.5% of the time. Thus,
despite the fact that these three networks characterized the
protein-ligand complexes of their respective validation sets
with the same accuracy, they were somewhat less consistent
when presented with new data. Under most circumstances,
it is not possible to know a priori which network is best
suited for a given database of protein-ligand complexes; a
more consistent result can be obtained by considering the
average score over multiple networks (N). Indeed, when the
average score over the top 24 networks was used to
characterize these protein-ligand complexes, an accuracy
of 94.1% was achieved.
Can N Distinguish between True and False Binders
When Both Are Well Docked? Although the networks were
successful at identifying poorly docked ligands, the ability
to distinguish between true high-afﬁnity binders and poor
binders when both are well docked is far more challenging.
To test the networks’ abilities, we docked 103 small-molecule
compounds into the active site of inﬂuenza N1 neuraminidase
(N1, PDB ID: 3B7E)
24 using AutoDock Vina.
23 Three of
these compounds were known neuraminidase inhibitors:
oseltamivir, peramivir, and zanamivir. The remaining 100
ligands were decoys selected at random from the NCI
Diversity Set II. We note that, of the 4141 protein-ligand
complexes used in the training and validation sets, one
consisted of zanamivir bound to N1, and two consisted of
oseltamivir bound to N1. However, no examples of peramivir
bound to N1 were present in the Protein Data Bank;
22 the
networks had never been exposed to this protein-ligand
complex.
The results of this small virtual screen are shown in Table
1. When the AutoDock Vina scoring function
23 was used to
rank the compounds, the known inhibitors ranked 5th, 10th,
and 55th. When the docked poses were rescored using each
of the top three individual neural networks, the known
inhibitors fared substantially better, with the predicted poorest
binder ranking 24th, 31st, and 9th, respectively. One of the
individual neural networks performed particularly well,
ranking the known inhibitors second, eighth, and ninth.
However, this network could not have been identiﬁed a priori.
When the compounds were ranked by the average score over
the top 24 networks (N), the known inhibitors performed
equally well. Had the top 10 compounds from this virtual
screen been subsequently tested experimentally, only the
network-based scoring functions would have permitted the
Figure 3. Average score (N) over 24 networks as a function of the
experimentally measured Kd value. To facilitate visualization,
the data were ordered by log10(Kd) value. Moving averages of both
the log10(Kd) values and the associated N values were calculated
over 100 points. This data-averaged function (shown in black)
crosses the x axis at 25 µM [log10(25 × 10-6) )- 4.60, shown as
a dotted line]. Individual, unaveraged data points are shown in gray.
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of such a virtual screen would have been 10.3.
To further validate the predictive potential of these neural
networks, we repeated the above virtual-screening protocol
using a crystal structure of T. brucei RNA editing ligase 1
(TbREL1), a protein that was not included in the 4141
protein-ligand complexes used in the training and validation
sets. As three positive controls (i.e., known inhibitors), we
chose ATP, the natural substrate, and compounds V1 and
S5, TbREL1 inhibitors recently identiﬁed by Amaro et al.
19
When the compounds were ranked by the average NNScore
score over the top 24 networks (N), two of the three known
inhibitors ranked in the top ten, giving an enrichment factor
of 6.87. This enrichment was equal to that obtained when
the compounds were ranked by the Vina scoring function
(Table 2).
This second screen illustrates several important points.
First, as mentioned above, each of the individual networks
has its own unique strengths and weaknesses. For example,
the network labeled NN1 was far better at identifying
compound V1 than was Vina, NN2 was better at identifying
ATP, and NN3 was better at identifying both ATP and V1
(Table 2). As we could not have known a priori which
network is best suited for this system, it is wise not to trust
the results of any single network. When the compounds were
ranked by the average output of the top 24 networks, ATP
and V1 still ranked in the top 10 compounds, but the result
was not dependent on a single network output.
A second point of interest illustrated by this screen is that,
for at least some systems, the networks’ unique approach to
binding-afﬁnity prediction might be orthogonal to more
traditional approaches. For example, in this second screen,
Vina identiﬁed S5 as a true binder, but the networks did
not; in contrast, the networks tended to be better at
identifying V1 and, with the notable exception of NN1, ATP.
By using the networks in conjunction with Vina, perhaps a
useful consensus score could be developed.
To test this hypothesis, a consensus score for each
compound was calculated by averaging the ranks obtained
when the Vina score and the NNScore score were used.
When the compounds were reranked by this consensus score,
ATP, V1, and S5 ranked ﬁrst, second, and eighth, respec-
tively. Assuming that the top 10 predicted inhibitors were
subsequently tested experimentally, ranking by this consensus
score would yield an enrichment factor of 10.3, superior to
the enrichment obtained when the compounds were ranked
by the Vina scoring function or the network outputs alone.
We recommend using positive controls (i.e., known inhibi-
tors) to determine whether a single scoring function or a
consensus score is best suited to a given virtual-screening
project.
CONCLUSIONS
The research presented here demonstrates that neural
networks can be used to successfully characterize the binding
afﬁnities of protein-ligand complexes. Not only were these
networks able to distinguish between well-docked and poorly
docked ligands, they were also able to distinguish between
true ligands and decoy compounds when both were well
docked. A user-friendly scoring function based on these
networks has been implemented in Python and can be
downloaded from http://www.nbcr.net/software/nnscore.
Although the networks’ success with the neuraminidase
and TbREL1 systems was promising, predictive accuracy
might be system dependent. Regardless, one strength of the
neural-network scoring function is that it is largely orthogonal
to other kinds of functions based on force ﬁelds, linear
regression, and statistical analyses. Thus, in many cases, it
could be useful to rank by consensus scores that combine
neural-network scoring functions with other more traditional
functions.
EXPERIMENTAL SECTION
Training/Testing Database Preparation. To build a
database of protein-ligand complexes of known binding
afﬁnity, we identiﬁed X-ray crystal and NMR structures from
the Protein Data Bank (PDB)
22 that had Kd values listed in
the MOAD
25 and PDBbind-CN
26,27 databases. Where mul-
tiple similar Kd values were present in these databases, Kd
values were averaged to give one value per protein-ligand
complex. Where multiple differing Kd values were present,
the corresponding complex was discarded. Additionally,
complexes with peptide or DNA ligands, ligands with rare
atom types (e.g., gold, copper, iron, zinc), receptors with
rare ligand-binding atom types (e.g., copper, nickel, cobalt),
and complexes with Kd values greater than 0.5 M were
likewise discarded. Ultimately, 2710 complexes remained.
Hydrogen atoms were added to the ligands of these
complexes using Schro ¨dinger Maestro (Schro ¨dinger). All
protonation states were veriﬁed by visual inspection. For
those complexes with ligand-binding metal cations, the partial
Table 1. Results of a Small Virtual Screen against Inﬂuenza N1









Vina 2/3 6.9 10 55 5
NN1 2/3 6.9 24 4 1
NN2 1/3 3.4 16 31 1
NN3 3/3 10.3 8 9 2
N (average24) 3/3 10.3 7 10 2
a Five scoring functions compared: AutoDock Vina score,
predictions of the top three individual neural networks (NN1,N N 2,
and NN3, respectively), and average prediction of the top 24
networks (N).
b Number of known inhibitors that ranked in the top
ten for each scoring function.
c Enrichment factor when the top 10
ligands were considered.
d Rank of the known inhibitor zanamivir.
e Rank of the known inhibitor oseltamivir.
f Rank of the known
inhibitor peramivir.
Table 2. Results of a Small Virtual Screen against Tb REL1 Used








Vina 2/3 6.9 8 18 9
NN1 1/3 3.4 99 2 25
NN2 1/3 3.4 2 16 24
NN3 2/3 6.9 7 1 69
N (average24) 2/3 6.9 8 5 27
a Five scoring functions compared: AutoDock Vina score,
predictions of the top three individual neural networks (NN1,N N 2,
and NN3, respectively), and average prediction of the top 24
networks (N).
b Number of known inhibitors that ranked in the top
10 for each scoring function.
c Enrichment factor when the top 10
ligands were considered.
d Rank of the known inhibitor ATP.
e Rank
of the known inhibitor V1.
f Rank of the known inhibitor S5.
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charge. The geometries of the hydrogen bonds between the
ligand and the receptor were optimized using an in-house
script. AutoDockTools 1.5.1
28 was used to add hydrogen
atoms to the receptors, to merge nonpolar hydrogen atoms
with their parent atoms, and to assign atom types and
Gasteiger charges. The ligand was likewise processed with
AutoDockTools.
Most of the protein-ligand interactions listed in the
MOAD and PDBbind-CN databases were high-afﬁnity; of
those used in the current study, for example, only about 25%
had Kd values greater than 25 µM. To include adequate
examples of weak-binding ligands, 20 randomly selected
ligands from the NCI Diversity Set II, a set of freely
available, diverse compounds provided by the Developmental
Therapeutics Program (NCI/NIH), were docked into each
of the receptors described above using AutoDock Vina.
23
In all, 1431 ligands with best predicted binding energies
between 0 and -4 kcal/mol were identiﬁed and included in
the database as examples of weak-binding ligands.
Poorly Docked Database Preparation. In addition to the
database of crystallographic and well-docked poses described
above, we also generated a separate database of poorly
docked protein-ligand complexes. Some of the ligands of
the training/testing database described above were docked
back into their corresponding receptors using AutoDock
Vina.
23 Rather than identifying the ligand pose with the best
predicted binding energy, the pose with the worst predicted
binding energy was considered. In 287 cases, this worst
predicted binding energy was greater than -4 kcal/mol; these
287 protein-ligand complexes were included in the poorly
docked database.
Inﬂuenza Neuraminidase Database Preparation. To
create a database of compounds docked into inﬂuenza
neuraminidase, three known neuraminidase inhibitors (os-
eltamivir, peramivir, and zanamivir) were docked into a
neuraminidase crystal structure obtained from the PDB (PDB
ID: 3B7E).
24 Additionally, 100 compounds were randomly
selected from the NCI Diversity Set II to serve as decoys.
All 103 compounds were docked into the neuraminidase
active site using AutoDock Vina.
23
TbREL1 Database Preparation. A database of com-
pounds docked into TbREL1 was similarly generated. Three
known ligands (ATP, V1, and S5
19) were docked into a
TbREL1 crystal structure (PDB ID: 1XDN).
29 As before,
100 compounds were randomly selected from the NCI
Diversity Set II to serve as decoys.
Characterization of Protein-Ligand Complexes. All
protein-ligand complexes were characterized in four ways.
First, close protein-ligand contacts were considered. Pairs
of ligand and protein atoms within2Åo feach other were
ﬁrst identiﬁed. These protein-ligand atom pairs were then
characterized according to the AutoDock atom types of their
two constituents, and the number of each of these close-
contact atom-type pairs was tallied in a list. Fourteen
protein-ligand atom-type pairs were permitted: (A, HD), (C,
HD), (C, OA), (C, SA), (FE, HD), (HD, HD), (HD, MG),
(HD, N), (HD, NA), (HD, OA), (HD, ZN), (MG, OA), (NA,
ZN), and (OA, ZN).
A similar list of close-contact atom-type pairs was tallied
for all protein-ligand atom pairs within4Åo feach other.
Eighty-three atom-type pairs were permitted: (A, A), (A,
BR), (A, C), (A, CL), (A, F), (A, FE), (A, HD), (A, I), (A,
N), (A, NA), (A, OA), (A, P), (A, S), (A, SA), (A, ZN),
(BR, C), (BR, HD), (BR, N), (BR, OA), (C, C), (C, CL),
(C, F), (C, FE), (C, HD), (C, I), (CL, HD), (CL, N), (CL,
OA), (CL, SA), (C, MG), (C, MN), (C, N), (C, NA), (C,
OA), (C, P), (C, S), (C, SA), (C, ZN), (FE, HD), (FE, N),
(FE, OA), (F, HD), (F, N), (F, OA), (F, SA), (HD, HD),
(HD, I), (HD, MG), (HD, MN), (HD, N), (HD, NA), (HD,
OA), (HD, P), (HD, S), (HD, SA), (HD, ZN), (I, N), (I, OA),
(MG, NA), (MG, OA), (MG, P), (MN, N), (MN, OA), (MN,
P), (NA, OA), (NA, SA), (NA, ZN), (N, N), (N, NA), (N,
OA), (N, P), (N, S), (N, SA), (N, ZN), (OA, OA), (OA, P),
(OA, S), (OA, SA), (OA, ZN), (P, ZN), (SA, SA), (SA, ZN),
and (S, ZN).
Second, the electrostatic-interaction energy between pro-
tein and ligand atoms within4Åo feach other was calculated
and summed for each of the atom-type pairs described above:
where qr is the partial charge of receptor atom r, ql is the
partial charge of ligand atom l, and d is the distance between
the two. The same atom-type pairs permitted for close-contact
protein-ligand atoms within4Åo feach other were again
used.
Third, a list of ligand atom types was likewise tallied, and
the number of atoms of each type was counted. Thirteen
ligand atom types were permitted: A, BR, C, CL, F, HD, I,
N, NA, OA, P, S, and SA. Finally, the number of ligand
rotatable bonds was likewise counted. In all, each protein-
ligand complex was thus characterized across 194 (14 + 83
+ 83 + 13 + 1) dimensions.
Neural-Network Setup. All neural networks were feed-
forward networks created using FFNET
30 with 194 inputs
and 2 outputs. All nodes in the hidden and output layers
had log-sigmoid activation functions of the form
where t is the input sum of the respective node. Network
inputs and outputs were normalized with a linear mapping
to the range (0.15, 0.85) so that each variable was given
equal initial importance independent of its scale. There were
no direct connections between the input and output layers;
all nodes of the hidden layer were connected to all nodes of
the input layer, and all nodes of the output layer were
connected to all nodes of the hidden layer.
The networks were trained to return (1, 0) for protein-
ligand complexes with experimentally measured Kd values
less than 25 µM, and (0, 1) for complexes with Kd values
greater than 25 µM. To train each network, the weights of
the connections between neurodes were ﬁrst randomly
assigned; these weights were subsequently optimized by
applying 10000 steps of a constrained truncated Newton
algorithm
31 as implemented in SciPy.
32
Training sets of varying sizes were employed. In all cases,
training sets consisted of protein-ligand complexes picked
at random from the 4141 complexes of the training/testing
database described above. The remaining complexes con-
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